Medicine / D-0816-2026
U.S. Food and Drug AdministrationD-0816-2026
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic,…
Class II Distributed nationwide or U.S.-wide
Status: Ongoing
What was recalled
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.
Recalling firm
Baxter Healthcare Corporation
Reason for recall
CGMP Deviations
Where it went
US Nationwide; Puerto Rico; and Chile.
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.